 LOS ALTOS, Calif.-- BUSINESS WIRE --RenovoRx, Inc. Nasdaq: RNXT, a biopharmaceutical company focused on the localized treatment of solid tumors, today announced that Shaun Bagai, Chief Executive Officer, is scheduled to present virtually at the Sequire Biotechnology Conference on Thursday, February 2, 2023 at 4 p.m. ET. To register for the event, visit the Sequire Biotechnology Conference website. 